Clinical Trials Logo

Clinical Trial Summary

To capture safety and efficacy when Nexium are administered to pediatric patients in clinical practice after launch


Clinical Trial Description

The objective of this investigation is to capture the followings when Nexium capsules or Nexium granules for suspension (single-dose package) are administered to pediatric patients in clinical practice after launch. 1. Development of adverse reactions which are unexpected from Precaution for Use 2. Development of adverse reactions 3. Efficacy ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03562026
Study type Observational
Source AstraZeneca
Contact
Status Completed
Phase
Start date June 28, 2018
Completion date November 5, 2020